Treatment of Hepatitis C and Anemia in Human Immunodeficiency Virus–Infected Patients
Data up to Jan 2025
Total Citations Per Year
Abstract
References (61)
Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
1998 • 9,382 citations
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 • 6,133 citations
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 • 3,550 citations
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
1999 • 3,083 citations
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
1998 • 2,374 citations
Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy
1998 • 2,112 citations
Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection
1997 • 2,097 citations
Surveillance for waterborne-disease outbreaks--United States, 1993-1994.
1996 • 2,061 citations
Hepatitis C
1994 • 1,906 citations
Recommendations for Prevention and Control of Hepatitis C Virus (HCV) Infection and HCV-Related Chronic Disease
1998 • 1,246 citations
Paroxetine for the Prevention of Depression Induced by High-Dose Interferon Alfa
2001 • 1,096 citations
Increasing Mortality Due to End-Stage Liver Disease in Patients with Human Immunodeficiency Virus Infection
2001 • 987 citations
Hepatotoxicity Associated With Antiretroviral Therapy in Adults Infected With Human Immunodeficiency Virus and the Role of Hepatitis C or B Virus Infection
2000 • 971 citations
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study
2000 • 917 citations
Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross-Sectional Analysis of the US Adult AIDS Clinical Trials Group
2002 • 745 citations
Long-Term Histologic Improvement and Loss of Detectable Intrahepatic HCV RNA in Patients with Chronic Hepatitis C and Sustained Response to Interferon-α Therapy
1997 • 571 citations
Mother-to-infant transmission of hepatitis C virus
1995 • 467 citations
Natural history of HIV infection in the_era of combination antiretroviral therapy
1999 • 461 citations
Management of hepatitis C
2003 • 453 citations
Epidemiology of Anemia in Human Immunodeficiency Virus (HIV)-Infected Persons: Results From the Multistate Adult and Adolescent Spectrum of HIV Disease Surveillance Project
1998 • 427 citations
Quantitative analysis of hepatitis C virus-specific CD8+T cells in peripheral blood and liver using peptide-MHC tetramers
1999 • 421 citations
Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe
1999 • 394 citations
Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy
2001 • 359 citations
Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions
1984 • 327 citations
Ribavirin Antagonizes the Effect of Azidothymidine on HIV Replication
1987 • 282 citations
10-year follow-up after interferon-? therapy for chronic hepatitis C
1998 • 279 citations
Characterization and Biological Effects of Recombinant Human Erythropoietin
1986 • 250 citations
Hepatitis C in the HIV (Human Immunodeficiency Virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): The Effect of Coinfection on Survival
1999 • 244 citations
Mechanisms of transfusion‐induced immunosuppression
1990 • 212 citations
Anemia and Survival in HIV Infection
1998 • 194 citations
Interferon for the Treatment of Chronic Hepatitis C in Patients Infected with Human Immunodeficiency Virus
1996 • 186 citations
HEMATOLOGIC COMPLICATIONS OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION AND THE ACQUIRED IMMUNODEFICIENCY SYNDROME
1997 • 171 citations
Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro
1987 • 167 citations
Safety of combination interferon alfa-2b/ribavirin therapy in chronic hepatitis C-relapsed and treatment-naive patients.
1999 • 163 citations
Ribavirin Induces Error-Prone Replication of GB Virus B in Primary Tamarin Hepatocytes
2001 • 159 citations
Recombinant Interferon- for Chronic Hepatitis C in Patients Positive for Antibody to Human Immunodeficiency Virus
1992 • 106 citations
Hepatitis C virus genotypes and quasispecies
1999 • 104 citations
Hepatitis c virus and human immunodeficiency virus: clinical issues in coinfection
1999 • 103 citations
Efficacy and safety of combination therapy with interferon-α2b and ribavirin for chronic hepatitis C in HIV-infected patients
2000 • 96 citations
Mechanism of the potentiating effect of ribavirin on the activity of 2‘,3‘-dideoxyinosine against human immunodeficiency virus.
1991 • 94 citations
Increased Vertical Transmission of Human Immunodeficiency Virus from Hepatitis C Virus‐Coinfected Mothers
1997 • 92 citations
Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report
2000 • 92 citations
Response to treatment of chronic hepatitis C with interferon α in patients infected with HIV-1 is associated with higher CD4+ cell count
1998 • 82 citations
Recombinant human erythropoietin and health-related quality of life of AIDS patients with anemia.
1994 • 77 citations
Epoetin alfa therapy for anaemia in HIV-infected patients: impact on quality of life
2000 • 75 citations
Chronic hepatitis C in HIV infection: feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirin
2001 • 68 citations
Consensus statement: Anemia in HIV infection—current trends, treatment options, and practice strategies
2000 • 63 citations
Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: Clinical Management Issues
2000 • 63 citations
Transfusion of blood components to persons infected with human immunodeficiency virus type 1: relationship to opportunistic infection
1994 • 61 citations
Antiretroviral Therapy and Declining AIDS Mortality in New York City
2003 • 54 citations
The effect of blood transfusion on T-suppressor cells in renal dialysis patients.
1981 • 54 citations
A Phase-I Study of the Safety, Pharmacokinetics, and Antiviral Activity of Combination Didanosine and Ribavirin in Patients with HIV-1 Disease
1996 • 50 citations
Human immunodeficiency virus type 1 activation after blood transfusion
1996 • 38 citations
Granulocyte Colony‐Stimulating Factor Increases CD4+T Cell Counts of Human Immunodeficiency Virus–Infected Patients Receiving Stable, Highly Active Antiretroviral Therapy: Results from a Randomized, Placebo‐Controlled Trial
2000 • 33 citations
Antiretroviral therapy and declining AIDS mortality in New York City
2000 • 32 citations
Experience with epoetin alfa and acquired immunodeficiency syndrome anemia.
1998 • 29 citations
Limits of Resistance Testing
2000 • 27 citations
Use of blood transfusion in management of anemia
1992 • 23 citations
Efficacy and safety of combination therapy with interferon-??2b and ribavirin for chronic hepatitis C in HIV-infected patients:
2000 • 23 citations
Viral kinetics and mathematical models
1999 • 23 citations
The Effect of Long‐Term Treatment with Granulocyte Colony‐Stimulating Factor on Hematopoiesis in HIV‐Infected Individuals
2000 • 19 citations
Cited By (0)
No citing papers found in database